Back to Search

MARK MATTHES, M.D.

M.D.

Orthopaedic Surgery Physician

NPI: 1972564334IndividualAccepts Medicare

Specialties, Licenses & Credentials

Orthopaedic Surgery PhysicianPrimary

Orthopaedic Surgery

Code: 207X00000X

32661(IA)

CMS Specialties

PrimaryORTHOPEDIC SURGERY

Education

UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)

Class of 1992

Research & Publications (20)

Genetic modifiers of retinal degeneration in the rd3 mouse.
PMID 18344445·Invest Ophthalmol Vis Sci·2008
7-preclinical
Intraocular CNTF reduces vision in normal rats in a dose-dependent manner.
PMID 18055829·Invest Ophthalmol Vis Sci·2007
7-preclinical
Neurotrophic factors minimize the retinal toxicity of verteporfin photodynamic therapy.
PMID 17197564·Invest Ophthalmol Vis Sci·2007
7-preclinical
[Treatment anxiety in oral and maxillofacial surgery].
PMID 16897101·Mund Kiefer Gesichtschir·2006
4-observational
Retinal damage caused by photodynamic therapy can be reduced using BDNF.
PMID 17249587·Adv Exp Med Biol·2006
7-preclinical
BDNF reduces the retinal toxicity of verteporfin photodynamic therapy.
PMID 15505074·Invest Ophthalmol Vis Sci·2004
7-preclinical
Photoreceptor degeneration in Pro23His and S334ter transgenic rats.
PMID 15180276·Adv Exp Med Biol·2003
7-preclinical
Inherited retinal dystrophy in Mer knockout mice.
PMID 15180261·Adv Exp Med Biol·2003
6-review
An RCS-like retinal dystrophy phenotype in mer knockout mice.
PMID 12556419·Invest Ophthalmol Vis Sci·2003
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 4 locations total

Address
450 LAUREL ST STE A
DES MOINES, IA 50314

Quick Facts

NPI
1972564334
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
4
Years in Practice
34
Publications
20

Are you this provider?

Claim Your Profile